-- Airgas, Akamai, Comtech, Kodak, Lululemon: U.S. Equity Movers
-- B y   L u   W a n g
-- 2010-12-09T21:41:07Z
-- http://www.bloomberg.com/news/2010-12-08/diamond-foods-linn-energy-stryker-verint-u-s-equity-preview.html
Shares of the following companies had
unusual moves in U.S. trading. Stock symbols are in parentheses
and prices are as of 4 p.m. in New York.  Asset managers advanced after Barclays Plc advised buying
the shares to benefit from an improving equity market.  Janus
Capital Group Inc.  (JNS US), the Denver-based money manager that
was boosted to “overweight” from “underweight,” gained 4.5
percent to $12.31.  Waddell & Reed Financial Inc.  (WDR US) and
 Legg Mason Inc.  (LM US), which were also raised to
“overweight,” advanced 3 percent to $34.12 and 2.1 percent to
$35.92, respectively.  On their first day of trading:  SemiLEDs Corp.  (LEDS US) surged 52 percent to $25.76. The
manufacturer of light emitting diode chips in Hsinchu, Taiwan,
sold 5.25 million shares at $17 each in an initial public
offering.  First Republic Bank  (FRC US) advanced 9.5 percent to
$27.92. The former Bank of America Corp. unit backed by Colony
Capital LLC and General Atlantic LLC raised $281 million selling
its initial public offering at the midpoint of the forecast
price range.  Bona Film Group Ltd.  (BONA US) slipped 22 percent to $6.60.
China’s largest privately owned film distributor sold 11.7
million American depositary receipts for $8.50 each.  Airgas Inc.  (ARG US) had the second-biggest decrease in the
Standard & Poor’s 500 Index, erasing 6.3 percent to $61.84.  Air
Products & Chemicals Inc.  (APD US) raised its hostile takeover
bid for the industrial-gas distributor to $70 a share and called
it the “best and final” offer. The new price is still shy of
the $78 desired by Airgas, suggesting “there’s a risk this is
the end game,” according to Laurence Alexander, an analyst with
Jefferies Group Inc.   Akamai Technologies Inc.  (AKAM US) had the fourth-biggest
decline in the S&P 500, sliding 3 percent to $52.50. The maker
of technology that speeds Internet traffic didn’t boost its
forecast during a presentation with analysts. Raymond James
Financial Inc. said in a note earlier today that a strong start
to the holiday online spending season may prompt the company to
increase its fourth-quarter projections.  American International Group Inc.  (AIG US) climbed 13
percent, the most since Feb. 10, to $47.78. The bailed-out
insurer made a deal that provides for repayment of the Federal
Reserve and sets the rules for its eventual exit from U.S.
control.  Arbitron Inc.  (ARB US) rose 19 percent, the most since
February 2000, to $37.22. The provider of audience ratings for
U.S. radio stations was increased to “overweight” from
“neutral” by JPMorgan Chase & Co.   Ciena Corp.  (CIEN US) rose the most in the Russell 1000
Index, surging 15 percent to $18.36. The maker of network gear
for the biggest U.S. phone companies reported fourth-quarter
sales of $417.6 million, beating the average analyst estimate by
3 percent.  Compellent Technologies Inc.  (CML US) fell 14 percent, the
most since April 8, to $29.04. The storage area network producer
is in exclusive talks to sell itself to Dell Inc. (DELL US) The
world’s third-largest personal-computer maker would acquire all
of the outstanding common stock of Compellent at a price of
$27.50 a share in cash, the two companies said. The price is an
18 percent discount to the company’s closing price yesterday.  Comtech Telecommunications Corp.  (CMTL US) fell 12 percent,
the most since July 21, to $27.71. The provider of mobile-data
communications equipment was cut to “equalweight” from
“overweight” at Stephens Inc.  Dean Foods Co.  (DF US) rose 13 percent, the most since
November 2008, to $8.39. The biggest U.S. dairy processor plans
to sell $400 million of eight-year senior notes, according to a
person familiar with the transaction. The company said proceeds
may be used to pay down a portion of its senior secured credit
facility.  Diamond Foods Inc.  (DMND US) climbed 10 percent to $50.59,
the highest price since it went public in July 2005. The nut
processor and distributor said second-quarter profit will be as
much as 91 cents a share, above the average analyst estimate in
a Bloomberg survey of 86 cents a share.  Eastman Kodak Co.  (EK US) had the third-biggest gain in the
S&P 500, rising 11 percent to $5.31. The photography company
rose past the average price of the last 200 days, a signal of
possible further gains, according to analysts who study charts
to make forecasts.       Goodyear Tire & Rubber Co.  (GT US) had the fourth-biggest
advance in the S&P 500, rising 10 percent to $11.55. The largest
U.S. tiremaker was raised to a “buy” from “underperform” at
Bank of America Corp.  Helen of Troy Ltd.  (HELE US) rallied 17 percent, the most
since March 2009, to $27.44. The maker of Vidal Sassoon and
Revlon hair-care products agreed to acquire the business of Kaz
Inc. for $260 million in cash.  Lululemon Athletica Inc.  (LULU US) jumped 14 percent to
$63.56, the highest price since it went public in July 2007. The
biggest Canadian athletic-wear retailer forecast fourth-quarter
profit to be at least 46 cents a share, topping the 41 cent-
average estimate of analysts.  Martek Biosciences Corp.  (MATK US) fell 11 percent, the
most since March 2009, to $21.33. The maker of nutritional oils
for foods and baby formula forecast first-quarter profit of 40
cents a share at most. The average analyst estimate in a
Bloomberg survey is for 42 cents a share.  Methode Electronics Inc.  (MEI US) rallied 10 percent, the
most since Jan. 8, to $12.98. The maker of remote controls and
touch-screens reported second-quarter earnings of 12 cents a
share, beating the 6-cent estimate by one analyst. Sales in the
same period were $106.6 million, topping the $92 million
projected by the analyst.  Mips Technologies Inc.  (MIPS US) gained 13 percent to
$15.23 for its biggest gain since Oct. 26. The Sunnyvale,
California-based designer of high-performance processors was
recommended by CNBC’s “Mad Money” host Jim Cramer, according
to TheStreet.com Inc.’s website.  Osiris Therapeutics Inc.  (OSIR US) jumped 10 percent, the
most since June 24, to $7.59. The Columbia, Maryland-based maker
of products for the regeneration of human connective tissues was
highlighted as the “Bull of the Day” by Zacks Equity Research.  Oxford Industries Inc.  (OXM US) dropped 17 percent, the
most since October 2007, to $23.07. The maker of Tommy Bahama
clothing reported third-quarter earnings before interest, taxes,
depreciation and amortization that missed the average of two
analyst forecasts by 41 percent, according to Bloomberg data.  Quiksilver Inc.  (ZQK US) rose 23 percent, the most since
March 12, to $5.68. The surfer-themed apparel maker may be
acquired by PPR SA (PP FP), the French owner of the Gucci and
Bottega Veneta luxury brands, La Tribune reported. PPR Chief
Executive Officer  Francois-Henri Pinault  has reestablished
contact with the company and with Rhone Capital, which holds a
19 percent stake in the Huntington Beach, California-based
company, according to the newspaper.  Range Resources Corp.  (RRC US) had the third-biggest
decline in the S&P 500, erasing 3.2 percent to $42.44. The oil-
and-gas operator was cut to “neutral” from “buy” at MKM
Partners.  SAIC Inc.  (SAI US) fell 6.4 percent to $15.17 for the
biggest retreat in the S&P 500. The defense contractor
specializing in computer services forecast fiscal-year 2012
earnings from continuing operations of $1.35 to $1.46. Analysts
estimate profit of $1.49, according to a Bloomberg survey.  Sirius XM Radio Inc.  (SIRI US) rallied 5.7 percent, the
most since July 7, to $1.39. Talk-show host  Howard Stern  said on
air that he will stay with the company for five more years.  Smithfield Foods Inc.  (SFD US) increased 11 percent, the
most since May 5, to $19.70. The U.S. pork processor reported
second-quarter adjusted earnings were 80 cents a share,
exceeding the 56-cent average estimate of analysts.  Teva Pharmaceutical Industries Ltd.  (TEVA US) gained 6.8
percent, the most since October 2008, to $52.63. The world’s
largest maker of generic drugs said its oral laquinimod drug was
successful in reducing relapse rates in multiple sclerosis
patients in a late-stage test.  To contact the reporter on this story;
 Lu Wang  in New York at   lwang8@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 